TRINITY BIOTECH PLC
Ownership & governance
Executives 5Directors 4Avg age 50Avg tenure 10.5y
JG
John Gillard
Chief Executive Officer
Age 45Since 2023-12-16Profile →
+8
Executives5
JG
John Gillard→
Chief Executive Officer
Age 45Since 2023-12-16
PM
Paul Murphy→
Director of Finance/CFO
—Since 2025-12-22
JO
Jacqueline O’Neill→
Chief Operating Officer
—Since 1996-12-31
GK
Gary Keating→
Chief Tech/Sci/R&D Officer
Age 53Since 2022-09-30
EK
Eibhlin Kelly→
Chief Tech/Sci/R&D Officer
Age 42Since 2015-08-31
Board of directors4
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Hunter Associates Investment Management LLC | 2.864 % | 536,210 |
| Yorkville Advisors Global LP | 1.202 % | 225,000 |
| Williams & Novak LLC | 0.575 % | 107,643 |
| Virtu Financial LLC | 0.1425 % | 26,676 |
| Moss Adams Wealth Advisors LLC | 0.1371 % | 25,666 |
Catalog · 2026-07-09
Registry officers9
| Name | Role | Since | Shares |
|---|---|---|---|
| Eibhlin Kelly | Chief Tech/Sci/R&D Officer | 2015-08-31 | - |
| Gary Keating | Chief Tech/Sci/R&D Officer | 2022-09-30 | - |
| Jacqueline O’Neill | Chief Operating Officer | 1996-12-31 | - |
| John Gillard | Chief Executive Officer | 2023-12-16 | - |
| Paul Murphy | Director of Finance/CFO | 2025-12-22 | - |
| Ronan O'Caoimh | Chairman | 1995-04-30 | - |
| Andrew Omidvar | Director/Board Member | 2023-09-28 | - |
| John Gillard | Director/Board Member | — | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.